October 26, 2015
Strensiq: First approved treatment for perinatal
Strensiq is the first treatment for perinatal, infantile and juvenile-onset hypophosphatasia (HPP) approved approved by FDA.
pharmaceutical daily
Pharmaceuticals, Biotechnology and Life Sciences
October 26, 2015
FDA approves Yondelis for metastatic liposarcoma
Food and Drug Administration (FDA) has approved YONDELIS (trabectedin) for the treatment of patients with unresectable (unable to be removed…
October 26, 2015
Anavex joins NASDAQ
Anavex Life Sciences Corp., has announced it would be trading its common stock on the NASDAQ, an American/Canadian stock exchange, one…
October 26, 2015
Medicine for treating pancreatic cancer approved in US
The U.S. Food and Drug Administration has approved Onivyde (irinotecan liposome injection), in combination with fluorouracil and leucovorin, to treat…
October 26, 2015
Cosentyx in Europe for psoriatic arthritis and ankylosing spondylitis
Novartis has announced that the Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of Cosentyx(TM) (secukinumab)…
October 21, 2015
Allergan’s Gel Drops show reduction in dry eye symptoms
REFRESH OPTIVE Gel Drops, a new aqueous gel expertly designed for patients who need or desire a more viscous artificial tear option to relieve their Dry Eye symptoms.
October 21, 2015
Prevalence of Marijuana Use Among U.S. Adults Doubles Over Past Decade
The percentage of Americans who reported using marijuana in the past year more than doubled between 2001-2002 and 2012-2013, and the increase in marijuana use disorder during that time was nearly as large.
October 21, 2015
Dechra closes Genera takeover
Dechra has announced that on the closing date of its Takeover Offer to acquire the shares in Genera not owned by…
October 20, 2015
$22.9 million in Planning Grants for Certified Community Behavioral Health Clinics
The Substance Abuse and Mental Health Services Administration (SAMHSA), in conjunction with the Centers for Medicare & Medicaid Services (CMS) and the Assistant Secretary of Planning and Evaluation (ASPE), today awarded a total of $22.9 million to support states throughout the nation in their efforts to improve behavioral health of their citizens by providing community-based mental and substance use disorder treatment.
October 20, 2015
HHS: New members of Advisory Council on Alzheimer’s Research, Care, and Services
Secretary of U.S. Department of Health & Human Services (HSS) Sylvia M. Burwell on Tuesday announced six new members to serve on the Advisory Council on Alzheimer’s Research, Care, and Services.